Prognostic value of MACC1 and c-met Expressions in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 15, Issue 7, 2012, Pages 399-403

  Hu, Xingsheng ^a   Fu, Xi ^a   Wen, Shimin ^a   Zou, Xinyi ^b   Liu, Yusong ^c  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^b Maternal and Child Care Service Centre of Shifang   (China)

^c Department of Clinical Laboratory   (China)

Author keywords

C met; Invasion; Lung neoplasms; MACC1; Metastasis; Prognosis

Indexed keywords

SCATTER FACTOR RECEPTOR;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; GENE; HEPATOCYTE GROWTH FACTOR RECEPTOR GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; METASTASIS ASSOCIATED IN COLON CANCER 1 GENE; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR INVASION;

EID: 84922685621     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2012.07.02     Document Type: Article

References (13)

1. Jema A, Bray F, Center MM, et al. Global Cancer Statistics. CA Cancer J Clin, 2011, 61(2): 69-90.
2. Stein U, Walther W, Arlt F, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nature Med, 2009, 15(1): 59-67.
3. Shirahata A, Sakata M, Kitamura Y, et al. MACC 1 as a marker for peritonealdisseminated gastric carcinoma. Anticancer Res, 2010, 30(9): 3441-3444.
4. Shirahata A, Fan W, Sakuraba K, et al. MACC1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res, 2011, 31(3): 777-780.
5. Qiu J, Huang P, Liu Q, et al. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med, 2011, 9: 166.
6. Zhang R, Shi H, Chen Z, et al. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res, 2011, 30: 83.
7. Chundong G, Uramoto H, Onitsuka T, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res, 2011, 31(4): 1141-1145.
8. Lv X. The effect of MACC1 on invasion and metastasis in prostate cancer cell lines (1E8/2B4). Wu Han. Huazhong University of Science and Technology. 2011. [Chinese source]
9. Wu J, Zhang X, Zhu YL. The expression of MACC1 in bladder carcinoma and clinicasignificance. Jiangsu Yi Yao, 2011, 37(1): 101-102. [Chinese source]
10. Shang C, Hong Y, Xue YX. The expression of MACC1 gene in brain glioma and the influence to apoptosis in U87 cell. Jie Pou Xue Jin Zhan, 2011, 17(1): 1-3. [Chinese source]
11. Yang SH, Long YM, Wang YX, et al. Influence of MACC1 gene expression on the proliferation and migration of SBC-5 lung cancer cells. Xian Dai Zhong Liu Yi Xue, 2011, 19(4): 633-636. [Chinese source]
12. Eder JP, Vande Woude GF, Boerner SA, et al. Novel therapeutic inhibitors of the c-met signaling pathway in cancer. Clin Cancer Res, 2009, 15(7): 2207-2214.
13. Graveel CR, DeGroot JD, Su Y, et al. Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer. Proc Natl Acad Sci USA, 2009, 106(31): 12909-12914.